{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:42Z","timestamp":1788998442582,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Science and Culture and Royan Institute","award":["99000150"],"award-info":[{"award-number":["99000150"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cyclophosphamide is a widely utilized chemotherapeutic agent for pediatric cancers, known to elicit adverse effects, including perturbation of the PI3K\/Akt\/mTOR and Hippo signaling pathways, thereby diminishing ovarian reserve and fertility potential in females. Consequently, this investigation delves into the mitigative effects of metformin on cyclophosphamide-induced ovarian impairment in prepubertal mice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Twenty-four 14-day-old NMRI female mice were distributed into four groups: Control (Cont), Cyclophosphamide (Cyc), Metformin (Met), and Metformin plus Cyclophosphamide (Met-Cyc). The Met-Cyc group was given daily doses of 150\u00a0mg\/kg metformin for 11 consecutive days and in parallel 3 intermittent doses of 65\u00a0mg\/kg cyclophosphamide once every three days. The Met and Cyc groups were given identical doses of Met or Cyc alone. The control group received normal saline treatment. On the 12<jats:sup>th<\/jats:sup> day, mice were sacrificed for analysis. Stereological methods were employed to measure the overall volume of the ovaries, including the medulla, cortex, and follicles, along with measuring anti-M\u00fcllerian hormone (AMH) levels using an ELISA kit. Furthermore, qRT-PCR was utilized to quantify the expression levels of genes, including <jats:italic>P53<\/jats:italic>, <jats:italic>Bax<\/jats:italic>, <jats:italic>Bcl-2<\/jats:italic>, <jats:italic>Rad-51<\/jats:italic>, <jats:italic>Pten<\/jats:italic>, <jats:italic>Mtor<\/jats:italic>, and <jats:italic>Yap-1<\/jats:italic>.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The findings demonstrate that metformin ameliorates cyclophosphamide-induced ovarian toxicity by increasing AMH levels and attenuating the excessive activation of primordial follicles, the ratio of growing to quiescent follicles, and follicular atresia. This protective effect is mediated by the downregulation of apoptosis-related genes, upregulation of the gene involved in a reparative pathway, and modulation of the PI3K\/Akt\/mTOR pathway evidenced by increased expression of <jats:italic>Pten<\/jats:italic>, <jats:italic>Mtor<\/jats:italic> and Hippo pathway by <jats:italic>Yap-1<\/jats:italic> expression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our results advocate for the potential of metformin as a viable therapeutic option for preserving ovarian function in cyclophosphamide-treated adolescent girls, given its favorable side effect profile and ability to improve cyclophosphamide-induced ovarian damage.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-024-01572-4","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T10:42:57Z","timestamp":1734604977000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Metformin protects prepubertal mice ovarian reserve against cyclophosphamide via regulation of the PI3K\/Akt\/mTOR signaling pathway and Yap-1"],"prefix":"10.1186","volume":"17","author":[{"given":"Negin","family":"Zatalian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azam","family":"Dalman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvaneh","family":"Afsharian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Hezavehei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Gourabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"key":"1572_CR1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3390\/cancers13020202","volume":"13","author":"K Michalczyk","year":"2021","unstructured":"Michalczyk K, Cymbaluk-P\u0142oska A. Fertility preservation and long-term monitoring of gonadotoxicity in girls, adolescents and young adults undergoing Cancer Treatment. Cancers. 2021;13:202.","journal-title":"Cancers"},{"key":"1572_CR2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/humupd\/dmz027","volume":"25","author":"N Spears","year":"2019","unstructured":"Spears N, Lopes F, Stefansdottir A, Rossi V, De Felici M, Anderson R, Klinger F. Ovarian damage from chemotherapy and current approaches to its protection. Hum Reprod Update. 2019;25:673\u201393.","journal-title":"Hum Reprod Update"},{"key":"1572_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13048-017-0350-3","volume":"10","author":"L Zhou","year":"2017","unstructured":"Zhou L, Xie Y, Li S, Liang Y, Qiu Q, Lin H, Zhang Q. Rapamycin prevents cyclophosphamide-induced over-activation of primordial follicle pool through PI3K\/Akt\/mTOR signaling pathway in vivo. J Ovarian Res. 2017;10:1\u201311.","journal-title":"J Ovarian Res"},{"key":"1572_CR4","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/biolre\/ioz215","volume":"102","author":"M Devos","year":"2020","unstructured":"Devos M, Grosbois J, Demeestere I. Interaction between PI3K\/AKT and Hippo pathways during in vitro follicular activation and response to fragmentation and chemotherapy exposure using a mouse immature ovary model. Biol Reprod. 2020;102:717\u201329.","journal-title":"Biol Reprod"},{"key":"1572_CR5","doi-asserted-by":"crossref","unstructured":"Feng J, Ma W-W, Li H-X, Pei X-Y, Deng S-L, Jia H, Ma W-Z. Melatonin prevents cyclophosphamide-induced primordial follicle loss by inhibiting ovarian granulosa cell apoptosis and maintaining AMH expression. Front Endocrinol. 2022;13.","DOI":"10.3389\/fendo.2022.895095"},{"key":"1572_CR6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1530\/JOE-18-0370","volume":"240","author":"Y Luan","year":"2019","unstructured":"Luan Y, Edmonds ME, Woodruff TK, Kim S-Y. Inhibitors of apoptosis protect the ovarian reserve from cyclophosphamide. J Endocrinol. 2019;240:243\u201356.","journal-title":"J Endocrinol"},{"key":"1572_CR7","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/molehr\/gaaa043","volume":"26","author":"KJ Szymanska","year":"2020","unstructured":"Szymanska KJ, Tan X, Oktay K. Unraveling the mechanisms of chemotherapy-induced damage to human primordial follicle reserve: road to developing therapeutics for fertility preservation and reversing ovarian aging. Mol Hum Reprod. 2020;26:553\u201366.","journal-title":"Mol Hum Reprod"},{"key":"1572_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.bpobgyn.2012.01.001","volume":"26","author":"KA Rodriguez-Wallberg","year":"2012","unstructured":"Rodriguez-Wallberg KA, Oktay K. Recent advances in oocyte and ovarian tissue cryopreservation and transplantation. Best Pract Res Clin Obstet Gynecol. 2012;26:391\u2013405.","journal-title":"Best Pract Res Clin Obstet Gynecol"},{"key":"1572_CR9","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/aogs.12934","volume":"95","author":"KA Rodriguez-Wallberg","year":"2016","unstructured":"Rodriguez-Wallberg KA, Tanbo T, Tinkanen H, Thurin\u2010Kjellberg A, Nedstrand E, Kitlinski ML, Macklon KT, Ernst E, Fedder J, Tiitinen A. Ovarian tissue cryopreservation and transplantation among alternatives for fertility preservation in the nordic countries\u2013compilation of 20 years of multicenter experience. Acta Obstet Gynecol Scand. 2016;95:1015\u201326.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1572_CR10","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.rbmo.2022.05.020","volume":"45","author":"L Eijkenboom","year":"2022","unstructured":"Eijkenboom L, Saedt E, Zietse C, Braat D, Beerendonk C, Peek R. Strategies to safely use cryopreserved ovarian tissue to restore fertility after cancer: a systematic review. Reprod Biomed Online. 2022;45:763\u201378.","journal-title":"Reprod Biomed Online"},{"key":"1572_CR11","doi-asserted-by":"publisher","first-page":"F35","DOI":"10.1530\/REP-19-0097","volume":"158","author":"H Roness","year":"2019","unstructured":"Roness H, Meirow D. FERTILITY PRESERVATION: follicle reserve loss in ovarian tissue transplantation. Reproduction. 2019;158:F35\u201344.","journal-title":"Reproduction"},{"key":"1572_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1089\/bio.2021.0159","volume":"21","author":"RS Barberino","year":"2023","unstructured":"Barberino RS, Silva RLS, Palheta Junior RC, Smitz JE, Matos MHT. Protective effects of antioxidants on cyclophosphamide-induced ovarian toxicity. Biopreserv Biobank. 2023;21:121\u201341.","journal-title":"Biopreserv Biobank"},{"key":"1572_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1126\/science.1086336","volume":"301","author":"DH Castrillon","year":"2003","unstructured":"Castrillon DH, Miao L, Kollipara R, Horner JW, DePinho RA. Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science. 2003;301:215\u20138.","journal-title":"Science"},{"key":"1572_CR14","doi-asserted-by":"publisher","first-page":"ra185162","DOI":"10.1126\/scitranslmed.3005402","volume":"5","author":"L Kalich-Philosoph","year":"2013","unstructured":"Kalich-Philosoph L, Roness H, Carmely A, Fishel-Bartal M, Ligumsky H, Paglin S, Wolf I, Kanety H, Sredni B, Meirow D. Cyclophosphamide triggers follicle activation and burnout; AS101 prevents follicle loss and preserves fertility. Sci Transl Med. 2013;5:ra185162\u2013185162.","journal-title":"Sci Transl Med"},{"key":"1572_CR15","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.2174\/138161210791033950","volume":"16","author":"M Falasca","year":"2010","unstructured":"Falasca M. PI3K\/Akt signalling pathway specific inhibitors: a novel strategy to sensitize cancer cells to anti-cancer drugs. Curr Pharm Design. 2010;16:1410\u20136.","journal-title":"Curr Pharm Design"},{"key":"1572_CR16","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3390\/cancers13020318","volume":"13","author":"R Zeng","year":"2021","unstructured":"Zeng R, Dong J. The Hippo signaling pathway in drug resistance in cancer. Cancers. 2021;13:318.","journal-title":"Cancers"},{"key":"1572_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fendo.2020.00191","volume":"11","author":"Z Lv","year":"2020","unstructured":"Lv Z, Guo Y. Metformin and its benefits for various diseases. Front Endocrinol. 2020;11:191.","journal-title":"Front Endocrinol"},{"key":"1572_CR18","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s10555-021-09977-z","volume":"40","author":"G Eibl","year":"2021","unstructured":"Eibl G, Rozengurt E, Metformin. Review of epidemiology and mechanisms of action in pancreatic cancer. Cancer Metastasis Rev. 2021;40:865\u201378.","journal-title":"Cancer Metastasis Rev"},{"key":"1572_CR19","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.diabres.2018.05.023","volume":"143","author":"R Mallik","year":"2018","unstructured":"Mallik R, Chowdhury TA. Metformin in cancer. Diabetes Res Clin Pract. 2018;143:409\u201319.","journal-title":"Diabetes Res Clin Pract"},{"key":"1572_CR20","doi-asserted-by":"publisher","first-page":"gaaa084","DOI":"10.1093\/molehr\/gaaa084","volume":"27","author":"C-C Huang","year":"2021","unstructured":"Huang C-C, Chou C-H, Yang Y-S, Ho H-N, Shun C-T, Wen W-F, Chen S-U, Chen M-J. Metformin: a novel promising option for fertility preservation during cyclophosphamide-based chemotherapy. Mol Hum Reprod. 2021;27:gaaa084.","journal-title":"Mol Hum Reprod"},{"key":"1572_CR21","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1038\/s41598-024-51990-z","volume":"14","author":"Y Yang","year":"2024","unstructured":"Yang Y, Tang X, Yao T, Zhang Y, Zhong Y, Wu S, Wang Y, Pan Z. Metformin protects ovarian granulosa cells in chemotherapy-induced premature ovarian failure mice through AMPK\/PPAR-\u03b3\/SIRT1 pathway. Sci Rep. 2024;14:1447.","journal-title":"Sci Rep"},{"key":"1572_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7:27.","journal-title":"J Basic Clin Pharm"},{"key":"1572_CR23","doi-asserted-by":"publisher","first-page":"607","DOI":"10.4103\/0253-7613.100387","volume":"44","author":"V Kumar","year":"2012","unstructured":"Kumar V, Bhandari U, Tripathi CD, Khanna G. Evaluation of antiobesity and cardioprotective effect of Gymnema sylvestre extract in murine model. Indian J Pharmacol. 2012;44:607.","journal-title":"Indian J Pharmacol"},{"key":"1572_CR24","unstructured":"Soleymani MM, Nourafshan A, Hamta A, Moumeni HR, Abnousi M, Mahmoudi M, Anvari M, Hazaveh M. Effects of vitamin E on ovarian tissue of rats following treatment with p-nonylphenol: a stereological study; 2010."},{"key":"1572_CR25","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1071\/RD18131","volume":"31","author":"Z Kalhori","year":"2019","unstructured":"Kalhori Z, Mehranjani MS, Azadbakht M, Shariatzadeh MA. L-Carnitine improves endocrine function and folliculogenesis by reducing inflammation, oxidative stress and apoptosis in mice following induction of polycystic ovary syndrome. Reprod Fertility Dev. 2019;31:282\u201393.","journal-title":"Reprod Fertility Dev"},{"key":"1572_CR26","doi-asserted-by":"publisher","first-page":"153752","DOI":"10.1016\/j.phymed.2021.153752","volume":"92","author":"Q Chen","year":"2021","unstructured":"Chen Q, Xu Z, Li X, Du D, Wu T, Zhou S, Yan W, Wu M, Jin Y, Zhang J. Epigallocatechin gallate and theaflavins independently alleviate cyclophosphamide-induced ovarian damage by inhibiting the overactivation of primordial follicles and follicular atresia. Phytomedicine. 2021;92:153752.","journal-title":"Phytomedicine"},{"key":"1572_CR27","doi-asserted-by":"publisher","first-page":"114431","DOI":"10.1016\/j.jep.2021.114431","volume":"280","author":"F Zhou","year":"2021","unstructured":"Zhou F, Song Y, Liu X, Zhang C, Li F, Hu R, Huang Y, Ma W, Song K, Zhang M. Si-Wu-Tang facilitates ovarian function through improving ovarian microenvironment and angiogenesis in a mouse model of premature ovarian failure. J Ethnopharmacol. 2021;280:114431.","journal-title":"J Ethnopharmacol"},{"key":"1572_CR28","doi-asserted-by":"publisher","first-page":"113789","DOI":"10.1016\/j.jep.2021.113789","volume":"277","author":"W Liu","year":"2021","unstructured":"Liu W, Chen Q, Liu Z, Weng Z, Nguyen TN, Feng J, Zhou S. Zihuai recipe alleviates cyclophosphamide-induced diminished ovarian reserve via suppressing PI3K\/AKT-mediated apoptosis. J Ethnopharmacol. 2021;277:113789.","journal-title":"J Ethnopharmacol"},{"key":"1572_CR29","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1080\/15376516.2018.1491662","volume":"28","author":"F Dehghani","year":"2018","unstructured":"Dehghani F, Aboutalebi H, Esmaeilpour T, Panjehshahin MR, Bordbar H. Effect of platelet-rich plasma (PRP) on ovarian structures in cyclophosphamide-induced ovarian failure in female rats: a stereological study. Toxicol Mech Methods. 2018;28:653\u20139.","journal-title":"Toxicol Mech Methods"},{"key":"1572_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12958-021-00743-y","volume":"19","author":"J Li","year":"2021","unstructured":"Li J, Long H, Cong Y, Gao H, Lyu Q, Yu S, Kuang Y. Quercetin prevents primordial follicle loss via suppression of PI3K\/Akt\/Foxo3a pathway activation in cyclophosphamide-treated mice. Reproductive Biology Endocrinol. 2021;19:1\u201311.","journal-title":"Reproductive Biology Endocrinol"},{"key":"1572_CR31","doi-asserted-by":"publisher","first-page":"116608","DOI":"10.1016\/j.jep.2023.116608","volume":"314","author":"Z Xiu","year":"2023","unstructured":"Xiu Z, Tang S, Kong P, Yan M, Tong X, Liu X, Liang X, Li R, Duan Y. Zigui-Yichong-Fang protects against cyclophosphamide-induced premature ovarian insufficiency via the SIRT1\/Foxo3a pathway. J Ethnopharmacol. 2023;314:116608.","journal-title":"J Ethnopharmacol"},{"key":"1572_CR32","doi-asserted-by":"publisher","first-page":"096032712211274","DOI":"10.1177\/09603271221127430","volume":"41","author":"H Xu","year":"2022","unstructured":"Xu H, Bao X, Kong H, Yang J, Li Y, Sun Z. Melatonin protects against cyclophosphamide-induced premature ovarian failure in rats. Hum Exp Toxicol. 2022;41:09603271221127430.","journal-title":"Hum Exp Toxicol"},{"key":"1572_CR33","doi-asserted-by":"crossref","unstructured":"Di Emidio G, Rossi G, Bonomo I, Alonso GL, Sferra R, Vetuschi A, Artini PG, Provenzani A, Falone S, Carta G. The natural carotenoid crocetin and the synthetic tellurium compound AS101 protect the ovary against cyclophosphamide by modulating SIRT1 and mitochondrial markers. Oxidative Med Cell Longevity. 2017;2017.","DOI":"10.1155\/2017\/8928604"},{"key":"1572_CR34","doi-asserted-by":"crossref","unstructured":"Barberino RS, Lins TLB, Monte AP, Gouveia BB, Campinho DS, Palheta RC, et al. Melatonin attenuates Cyclophosphamide-Induced primordial follicle loss by Interaction with MT1 receptor and modulation of PTEN\/Akt\/FOXO3a proteins in the mouse ovary. Reproductive Sci. 2022;29:2505\u201314.","DOI":"10.1007\/s43032-021-00768-z"},{"key":"1572_CR35","unstructured":"Liu X, Song Y, Zhou F, Zhang C, Li F, Hu R, Ma W, Song K, Tang Z, Zhang M. Si-Wu-Tang. Improves ovarian function by regulating follicular development via PI3K\/AKT signaling pathway in a mouse model of premature ovarian failure induced by cyclophosphamide. Available at SSRN 4008141."},{"key":"1572_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2016.10.011","volume":"596","author":"Y Xiong","year":"2017","unstructured":"Xiong Y, Liu T, Wang S, Chi H, Chen C, Zheng J. Cyclophosphamide promotes the proliferation inhibition of mouse ovarian granulosa cells and premature ovarian failure by activating the lncRNA-Meg3-p53-p66Shc pathway. Gene. 2017;596:1\u20138.","journal-title":"Gene"},{"key":"1572_CR37","doi-asserted-by":"publisher","first-page":"6311","DOI":"10.3390\/ijms20246311","volume":"20","author":"S Wang","year":"2019","unstructured":"Wang S, Lin S, Zhu M, Li C, Chen S, Pu L, Lin J, Cao L, Zhang Y. Acupuncture reduces apoptosis of granulosa cells in rats with premature ovarian failure via restoring the PI3K\/Akt signaling pathway. Int J Mol Sci. 2019;20:6311.","journal-title":"Int J Mol Sci"},{"key":"1572_CR38","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1177\/1933719111426599","volume":"19","author":"Z Barekati","year":"2012","unstructured":"Barekati Z, Golkar-Narenji A, Totonchi M, Radpour R, Gourabi H. Effects of amifostine in combination with cyclophosphamide on female reproductive system. Reproductive Sci. 2012;19:539\u201346.","journal-title":"Reproductive Sci"},{"key":"1572_CR39","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.3390\/pharmaceutics14122769","volume":"14","author":"A Al-Shahat","year":"2022","unstructured":"Al-Shahat A, Hulail MA, Soliman NM, Khamis T, Fericean LM, Arisha AH, Moawad RS. Melatonin mitigates Cisplatin-Induced Ovarian Dysfunction via altering steroidogenesis, inflammation, apoptosis, oxidative stress, and PTEN\/PI3K\/Akt\/mTOR\/AMPK signaling pathway in female rats. Pharmaceutics. 2022;14:2769.","journal-title":"Pharmaceutics"},{"key":"1572_CR40","doi-asserted-by":"crossref","unstructured":"Liu H, Yang H, Qin Z, Chen Y, Yu H, Li W, Zhu X, Cai J, Chen J, Zhang M. Exploration of the Danggui Buxue decoction mechanism regulating the balance of ESR and AR in the TP53-AKT signaling pathway in the prevention and treatment of POF. Evid Complementary Alternative Med. 2021;2021.","DOI":"10.1155\/2021\/4862164"},{"key":"1572_CR41","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.taap.2014.11.017","volume":"282","author":"S Ganesan","year":"2015","unstructured":"Ganesan S, Keating AF. Phosphoramide mustard exposure induces DNA adduct formation and the DNA damage repair response in rat ovarian granulosa cells. Toxicol Appl Pharmcol. 2015;282:252\u20138.","journal-title":"Toxicol Appl Pharmcol"},{"key":"1572_CR42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.febslet.2004.08.034","volume":"575","author":"Y-J Choi","year":"2004","unstructured":"Choi Y-J, Ok D-W, Kwon D-N, Chung J-i, Kim H-C, Yeo S-M, Kim T, Seo H-G, Kim J-H. Murine male germ cell apoptosis induced by busulfan treatment correlates with loss of c-kit-expression in a Fas\/FasL-and p53-independent manner. FEBS Lett. 2004;575:41\u201351.","journal-title":"FEBS Lett"},{"key":"1572_CR43","doi-asserted-by":"crossref","unstructured":"Su C, Zhang R, Zhang X, Lv M, Liu X, Ao K, et al. Dingkun Pill modulate ovarian function in chemotherapy-induced premature ovarian insufficiency mice by regulating PTEN\/PI3K\/AKT\/FOXO3a signaling pathway. J Ethnopharmacol. 2023;315:116703.","DOI":"10.1016\/j.jep.2023.116703"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-024-01572-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-024-01572-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-024-01572-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T11:07:51Z","timestamp":1734606471000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-024-01572-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1572"],"URL":"https:\/\/doi.org\/10.1186\/s13048-024-01572-4","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,19]]},"assertion":[{"value":"6 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by Royan Institute (approval ID: IR.ACECR.ROYAN.REC.1399.124).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.\u00a0","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"251"}}